1
|
Karamikamkar S, Yalcintas EP, Haghniaz R, de Barros NR, Mecwan M, Nasiri R, Davoodi E, Nasrollahi F, Erdem A, Kang H, Lee J, Zhu Y, Ahadian S, Jucaud V, Maleki H, Dokmeci MR, Kim H, Khademhosseini A. Aerogel-Based Biomaterials for Biomedical Applications: From Fabrication Methods to Disease-Targeting Applications. Adv Sci (Weinh) 2023; 10:e2204681. [PMID: 37217831 PMCID: PMC10427407 DOI: 10.1002/advs.202204681] [Citation(s) in RCA: 4] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/03/2023] [Indexed: 05/24/2023]
Abstract
Aerogel-based biomaterials are increasingly being considered for biomedical applications due to their unique properties such as high porosity, hierarchical porous network, and large specific pore surface area. Depending on the pore size of the aerogel, biological effects such as cell adhesion, fluid absorption, oxygen permeability, and metabolite exchange can be altered. Based on the diverse potential of aerogels in biomedical applications, this paper provides a comprehensive review of fabrication processes including sol-gel, aging, drying, and self-assembly along with the materials that can be used to form aerogels. In addition to the technology utilizing aerogel itself, it also provides insight into the applicability of aerogel based on additive manufacturing technology. To this end, how microfluidic-based technologies and 3D printing can be combined with aerogel-based materials for biomedical applications is discussed. Furthermore, previously reported examples of aerogels for regenerative medicine and biomedical applications are thoroughly reviewed. A wide range of applications with aerogels including wound healing, drug delivery, tissue engineering, and diagnostics are demonstrated. Finally, the prospects for aerogel-based biomedical applications are presented. The understanding of the fabrication, modification, and applicability of aerogels through this study is expected to shed light on the biomedical utilization of aerogels.
Collapse
Affiliation(s)
| | | | - Reihaneh Haghniaz
- Terasaki Institute for Biomedical Innovation (TIBI)Los AngelesCA90024USA
| | | | - Marvin Mecwan
- Terasaki Institute for Biomedical Innovation (TIBI)Los AngelesCA90024USA
| | - Rohollah Nasiri
- Terasaki Institute for Biomedical Innovation (TIBI)Los AngelesCA90024USA
| | - Elham Davoodi
- Terasaki Institute for Biomedical Innovation (TIBI)Los AngelesCA90024USA
- Department of Mechanical and Mechatronics EngineeringUniversity of WaterlooWaterlooONN2L 3G1Canada
| | - Fatemeh Nasrollahi
- Terasaki Institute for Biomedical Innovation (TIBI)Los AngelesCA90024USA
- Department of BioengineeringUniversity of California‐Los Angeles (UCLA)Los AngelesCA90095USA
| | - Ahmet Erdem
- Department of Biomedical EngineeringKocaeli UniversityUmuttepe CampusKocaeli41001Turkey
| | - Heemin Kang
- Department of Materials Science and EngineeringKorea UniversitySeoul02841Republic of Korea
| | - Junmin Lee
- Department of Materials Science and EngineeringPohang University of Science and Technology (POSTECH)Pohang37673Republic of Korea
| | - Yangzhi Zhu
- Terasaki Institute for Biomedical Innovation (TIBI)Los AngelesCA90024USA
| | - Samad Ahadian
- Terasaki Institute for Biomedical Innovation (TIBI)Los AngelesCA90024USA
| | - Vadim Jucaud
- Terasaki Institute for Biomedical Innovation (TIBI)Los AngelesCA90024USA
| | - Hajar Maleki
- Institute of Inorganic ChemistryDepartment of ChemistryUniversity of CologneGreinstraße 650939CologneGermany
- Center for Molecular Medicine CologneCMMC Research CenterRobert‐Koch‐Str. 2150931CologneGermany
| | | | - Han‐Jun Kim
- Terasaki Institute for Biomedical Innovation (TIBI)Los AngelesCA90024USA
- College of PharmacyKorea UniversitySejong30019Republic of Korea
| | - Ali Khademhosseini
- Terasaki Institute for Biomedical Innovation (TIBI)Los AngelesCA90024USA
| |
Collapse
|
2
|
Rabizadeh F, Amini E, Nasrollahi F. The Anatomical and Micromorphological Properties of Endemic Species to Gypsic Soils of Semnan, Iran. J Struct Biol 2023; 215:107968. [PMID: 37127092 DOI: 10.1016/j.jsb.2023.107968] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/09/2022] [Revised: 04/16/2023] [Accepted: 04/25/2023] [Indexed: 05/03/2023]
Abstract
The gypsum habitats of Iran are significant reserves of biodiversity containing endemic and rare species. Despite the limited understanding of its characteristics and habitat, it has become essential to study the endemic species of the Semnan gypsic soil. Fresh samples of studied species including Acantholimon cymosum, Astragalus fridae, Astragalus semnanensis, Euphorbia gypsicola, Gypsophila mucronofolia, Moltkia gypsaceae and Nepeta eremokosmus were collected in the wild during the growth season. Leaf surface and leaf cross-sections were considered. The longest hair length was related to A. fridae, A. semnanensis and M. gypsaceae species. The shorter hairs belong to the species A. cymosum, G. mucronofolia and E. gypsicola. Crystals called cystolites were seen in the epidermal cell wall of A. semnanensis leaves. The anatomical characteristics of these species' leaves indicate the presence of dry structures. Using micromorphological studies, we analyzed the hairs of the studied species in terms of their shapes, sizes, and densities. We found some species have hairs with special appendages, which is due to the special conditions in which they have grown. Xeromorphic stomata were found on both leaf surfaces of all endemic gypsophyte plants of Semnan. Several studies have shown that gypsophytes have a specialized mechanism for regulating the absorption of sulfur and calcium from soils containing calcium sulfate or gypsum by their roots. The current study provides novel insights into the response of plant species to extreme conditions and potential adaptation strategies at micromorphological levels.
Collapse
Affiliation(s)
| | - Elham Amini
- Department of Biology, Faculty of Sciences, Gonbad Kavous University, Gonbad, Iran
| | - Fatemeh Nasrollahi
- Department of Biology, Faculty of Sciences, University of Qom, Qom, Iran
| |
Collapse
|
3
|
Tavafoghi M, Nasrollahi F, Karamikamkar S, Mahmoodi M, Nadine S, Mano JF, Darabi MA, Jahangiry J, Ahadian S, Khademhosseini A. Advances and challenges in developing smart, multi-functional microneedles for biomedical applications. Biotechnol Bioeng 2022; 119:2715-2730. [PMID: 35854645 DOI: 10.1002/bit.28186] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/02/2022] [Revised: 07/14/2022] [Accepted: 07/15/2022] [Indexed: 11/08/2022]
Abstract
Microneedles (MNs) have been developed as minimally invasive tools for diagnostic and therapeutic applications. However, in recent years, there has been an increasing interest in developing smart multi-functional MN devices to provide automated and closed-loop systems for body fluid extraction, biosensing, and drug delivery in a stimuli-responsive manner. Although this technology is still in its infancy and far from being translated into the clinic, preclinical trials have shown some promise for the broad applications of multi-functional MN devices. The main challenge facing the fabrication of smart MN patches is the integration of multiple modules, such as drug carriers, highly sensitive biosensors, and data analyzers in one miniaturized MN device. Researchers have shown the feasibility of creating smart MNs by integrating stimuli-responsive biomaterials and advanced microscale technologies, such as microsensors and microfluidic systems, to precisely control the transportation of biofluids and drugs throughout the system. These multi-functional MN devices can be envisioned in two distinct strategies. The first type includes individual drug delivery and biosensing MN units with a microfluidic system and a digital analyzer responsible for fluid transportation and communication between these two modules. The second type relies on smart biomaterials that can function as drug deliverers and biosensors by releasing drugs in a stimuli-responsive manner. These smart biomaterials can undergo structural changes when exposed to external stimuli, such as pH and ionic changes, mimicking the biological systems. Studies have demonstrated a high potential of hydrogel-based MN devices for a wide variety of biomedical applications, such as drug and cell delivery, as well as interstitial fluid extraction. Biodegradable hydrogels have also been advantageous for fabricating multi-functional MNs due to their high loading capacity and biocompatibility with the drug of choice. Here, we first review a set of MN devices that can be employed either for biosensing or delivery of multiple target molecules and compare them to the conventional and more simple systems, which are mainly designed for single-molecule sensing or delivery. Subsequently, we expand our insight into advanced MN systems with multiple competencies, such as body fluid extraction, biosensing, and drug delivery at the point of care. The improvement of biomaterials knowledge and biofabrication techniques will allow us to efficiently tune the next generation of smart MNs and provide a realistic platform for more effective personalized therapeutics. This article is protected by copyright. All rights reserved.
Collapse
Affiliation(s)
- Maryam Tavafoghi
- Department of Bioengineering, University of California, Los Angeles, California, USA
| | - Fatemeh Nasrollahi
- Department of Bioengineering, University of California, Los Angeles, California, USA.,Terasaki Institute for Biomedical Innovation, Los Angeles, California, USA
| | | | - Mahboobeh Mahmoodi
- Department of Bioengineering, University of California, Los Angeles, California, USA.,Department of Biomedical Engineering, Yazd Branch, Islamic Azad University, Yazd, Iran
| | - Sara Nadine
- Terasaki Institute for Biomedical Innovation, Los Angeles, California, USA.,CICECO - Aveiro Institute of Materials, Department of Chemistry, University of Aveiro, Campus Universitário de Santiago, Aveiro, Portugal
| | - João F Mano
- CICECO - Aveiro Institute of Materials, Department of Chemistry, University of Aveiro, Campus Universitário de Santiago, Aveiro, Portugal
| | | | - Jamileh Jahangiry
- Department of Bioengineering, University of California, Los Angeles, California, USA
| | - Samad Ahadian
- Terasaki Institute for Biomedical Innovation, Los Angeles, California, USA
| | - Ali Khademhosseini
- Terasaki Institute for Biomedical Innovation, Los Angeles, California, USA
| |
Collapse
|
4
|
Amirifar L, Besanjideh M, Nasiri R, Shamloo A, Nasrollahi F, de Barros NR, Davoodi E, Erdem A, Mahmoodi M, Hosseini V, Montazerian H, Jahangiry J, Darabi MA, Haghniaz R, Dokmeci MR, Annabi N, Ahadian S, Khademhosseini A. Droplet-based microfluidics in biomedical applications. Biofabrication 2021; 14. [PMID: 34781274 DOI: 10.1088/1758-5090/ac39a9] [Citation(s) in RCA: 29] [Impact Index Per Article: 9.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/19/2021] [Accepted: 11/15/2021] [Indexed: 11/11/2022]
Abstract
Droplet-based microfluidic systems have been employed to manipulate discrete fluid volumes with immiscible phases. Creating the fluid droplets at microscale has led to a paradigm shift in mixing, sorting, encapsulation, sensing, and designing high throughput devices for biomedical applications. Droplet microfluidics has opened many opportunities in microparticle synthesis, molecular detection, diagnostics, drug delivery, and cell biology. In the present review, we first introduce standard methods for droplet generation (i.e., passive and active methods) and discuss the latest examples of emulsification and particle synthesis approaches enabled by microfluidic platforms. Then, the applications of droplet-based microfluidics in different biomedical applications are detailed. Finally, a general overview of the latest trends along with the perspectives and future potentials in the field are provided.
Collapse
Affiliation(s)
- Leyla Amirifar
- Mechanical Engineering, Sharif University of Technology, Tehran, Iran, Tehran, 11365-11155, Iran (the Islamic Republic of)
| | - Mohsen Besanjideh
- Department of Mechanical Engineering, Sharif University of Technology, Tehran, Tehran, 11365-11155, Iran (the Islamic Republic of)
| | - Rohollah Nasiri
- Department of Mechanical Engineering, Sharif University of Technology, Tehran, Tehran, 11365-11155, Iran (the Islamic Republic of)
| | - Amir Shamloo
- Department of Mechanical Engineering, Sharif University of Technology, Tehran, Tehran, 11365-11155, Iran (the Islamic Republic of)
| | | | - Natan Roberto de Barros
- Terasaki Institute for Biomedical Innovation (TIBI), Los Angeles, Los Angeles, 90024, UNITED STATES
| | - Elham Davoodi
- Bioengineering, University of California - Los Angeles, Los Angeles, Los Angeles, 90095, UNITED STATES
| | - Ahmet Erdem
- Bioengineering, University of California - Los Angeles, Los Angeles, Los Angeles, 90095, UNITED STATES
| | | | - Vahid Hosseini
- Terasaki Institute for Biomedical Innovation (TIBI), Los Angeles, Los Angeles, 90024, UNITED STATES
| | - Hossein Montazerian
- Bioengineering, University of California - Los Angeles, Los Angeles, Los Angeles, 90095, UNITED STATES
| | - Jamileh Jahangiry
- University of California - Los Angeles, Los Angeles, Los Angeles, 90095, UNITED STATES
| | | | - Reihaneh Haghniaz
- Terasaki Institute for Biomedical Innovation (TIBI), Los Angeles, Los Angeles, 90024, UNITED STATES
| | - Mehmet R Dokmeci
- Terasaki Institute for Biomedical Innovation (TIBI), Los Angeles, Los Angeles, 90024, UNITED STATES
| | - Nasim Annabi
- Chemical Engineering, UCLA, Los Angeles, Los Angeles, California, 90095, UNITED STATES
| | - Samad Ahadian
- Terasaki Institute for Biomedical Innovation (TIBI), Los Angeles, Los Angeles, 90024, UNITED STATES
| | - Ali Khademhosseini
- Terasaki Institute for Biomedical Innovation (TIBI), Los Angeles, Los Angeles, 90024, UNITED STATES
| |
Collapse
|
5
|
Nasrollahi F, Haghniaz R, Hosseini V, Davoodi E, Mahmoodi M, Karamikamkar S, Darabi MA, Zhu Y, Lee J, Diltemiz SE, Montazerian H, Sangabathuni S, Tavafoghi M, Jucaud V, Sun W, Kim H, Ahadian S, Khademhosseini A. Micro and Nanoscale Technologies for Diagnosis of Viral Infections. Small 2021; 17:e2100692. [PMID: 34310048 PMCID: PMC8420309 DOI: 10.1002/smll.202100692] [Citation(s) in RCA: 13] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/02/2021] [Revised: 03/19/2021] [Indexed: 05/16/2023]
Abstract
Viral infection is one of the leading causes of mortality worldwide. The growth of globalization significantly increases the risk of virus spreading, making it a global threat to future public health. In particular, the ongoing coronavirus disease 2019 (COVID-19) pandemic outbreak emphasizes the importance of devices and methods for rapid, sensitive, and cost-effective diagnosis of viral infections in the early stages by which their quick and global spread can be controlled. Micro and nanoscale technologies have attracted tremendous attention in recent years for a variety of medical and biological applications, especially in developing diagnostic platforms for rapid and accurate detection of viral diseases. This review addresses advances of microneedles, microchip-based integrated platforms, and nano- and microparticles for sampling, sample processing, enrichment, amplification, and detection of viral particles and antigens related to the diagnosis of viral diseases. Additionally, methods for the fabrication of microchip-based devices and commercially used devices are described. Finally, challenges and prospects on the development of micro and nanotechnologies for the early diagnosis of viral diseases are highlighted.
Collapse
Affiliation(s)
- Fatemeh Nasrollahi
- Terasaki Institute for Biomedical Innovation (TIBI)Los AngelesCA90024USA
- Department of BioengineeringUniversity of California‐Los AngelesLos AngelesCA90095USA
| | - Reihaneh Haghniaz
- Terasaki Institute for Biomedical Innovation (TIBI)Los AngelesCA90024USA
- Department of BioengineeringUniversity of California‐Los AngelesLos AngelesCA90095USA
| | - Vahid Hosseini
- Terasaki Institute for Biomedical Innovation (TIBI)Los AngelesCA90024USA
- Department of BioengineeringUniversity of California‐Los AngelesLos AngelesCA90095USA
| | - Elham Davoodi
- Terasaki Institute for Biomedical Innovation (TIBI)Los AngelesCA90024USA
- Department of BioengineeringUniversity of California‐Los AngelesLos AngelesCA90095USA
- Department of Mechanical and Mechatronics EngineeringUniversity of WaterlooWaterlooONN2L 3G1Canada
| | - Mahboobeh Mahmoodi
- Department of BioengineeringUniversity of California‐Los AngelesLos AngelesCA90095USA
- Department of Biomedical EngineeringYazd BranchIslamic Azad UniversityYazd8915813135Iran
| | | | - Mohammad Ali Darabi
- Terasaki Institute for Biomedical Innovation (TIBI)Los AngelesCA90024USA
- Department of BioengineeringUniversity of California‐Los AngelesLos AngelesCA90095USA
| | - Yangzhi Zhu
- Terasaki Institute for Biomedical Innovation (TIBI)Los AngelesCA90024USA
| | - Junmin Lee
- Terasaki Institute for Biomedical Innovation (TIBI)Los AngelesCA90024USA
| | - Sibel Emir Diltemiz
- Department of BioengineeringUniversity of California‐Los AngelesLos AngelesCA90095USA
- Department of ChemistryFaculty of ScienceEskisehir Technical UniversityEskisehir26470Turkey
| | - Hossein Montazerian
- Terasaki Institute for Biomedical Innovation (TIBI)Los AngelesCA90024USA
- Department of BioengineeringUniversity of California‐Los AngelesLos AngelesCA90095USA
| | | | - Maryam Tavafoghi
- Department of BioengineeringUniversity of California‐Los AngelesLos AngelesCA90095USA
| | - Vadim Jucaud
- Terasaki Institute for Biomedical Innovation (TIBI)Los AngelesCA90024USA
| | - Wujin Sun
- Terasaki Institute for Biomedical Innovation (TIBI)Los AngelesCA90024USA
| | - Han‐Jun Kim
- Terasaki Institute for Biomedical Innovation (TIBI)Los AngelesCA90024USA
| | - Samad Ahadian
- Terasaki Institute for Biomedical Innovation (TIBI)Los AngelesCA90024USA
| | - Ali Khademhosseini
- Terasaki Institute for Biomedical Innovation (TIBI)Los AngelesCA90024USA
| |
Collapse
|
6
|
Tavafoghi M, Darabi MA, Mahmoodi M, Tutar R, Xu C, Mirjafari A, Billi F, Swieszkowski W, Nasrollahi F, Ahadian S, Hosseini V, Khademhosseini A, Ashammakhi N. Multimaterial bioprinting and combination of processing techniques towards the fabrication of biomimetic tissues and organs. Biofabrication 2021; 13. [PMID: 34130266 DOI: 10.1088/1758-5090/ac0b9a] [Citation(s) in RCA: 27] [Impact Index Per Article: 9.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/04/2021] [Accepted: 06/15/2021] [Indexed: 12/11/2022]
Abstract
Tissue reconstruction requires the utilization of multiple biomaterials and cell types to replicate the delicate and complex structure of native tissues. Various three-dimensional (3D) bioprinting techniques have been developed to fabricate customized tissue structures; however, there are still significant challenges, such as vascularization, mechanical stability of printed constructs, and fabrication of gradient structures to be addressed for the creation of biomimetic and complex tissue constructs. One approach to address these challenges is to develop multimaterial 3D bioprinting techniques that can integrate various types of biomaterials and bioprinting capabilities towards the fabrication of more complex structures. Notable examples include multi-nozzle, coaxial, and microfluidics-assisted multimaterial 3D bioprinting techniques. More advanced multimaterial 3D printing techniques are emerging, and new areas in this niche technology are rapidly evolving. In this review, we briefly introduce the basics of individual 3D bioprinting techniques and then discuss the multimaterial 3D printing techniques that can be developed based on combination of these techniques for the engineering of complex and biomimetic tissue constructs. We also discuss the perspectives and future directions to develop state-of-the-art multimaterial 3D bioprinting techniques for engineering tissues and organs.
Collapse
Affiliation(s)
- Maryam Tavafoghi
- Center for Minimally Invasive Therapeutics (C-MIT), University of California, Los Angeles, CA, United States of America.,Department of Bioengineering, University of California, Los Angeles, CA, United States of America
| | - Mohammad Ali Darabi
- Center for Minimally Invasive Therapeutics (C-MIT), University of California, Los Angeles, CA, United States of America.,Department of Bioengineering, University of California, Los Angeles, CA, United States of America.,Department of Radiological Sciences, David Geffen School of Medicine, University of California, Los Angeles, CA, United States of America.,Terasaki Institute for Biomedical Innovation, Los Angeles, CA, United States of America
| | - Mahboobeh Mahmoodi
- Center for Minimally Invasive Therapeutics (C-MIT), University of California, Los Angeles, CA, United States of America.,Department of Bioengineering, University of California, Los Angeles, CA, United States of America.,Department of Biomedical Engineering, Yazd Branch, Islamic Azad University, Yazd, Iran
| | - Rumeysa Tutar
- Center for Minimally Invasive Therapeutics (C-MIT), University of California, Los Angeles, CA, United States of America.,Department of Bioengineering, University of California, Los Angeles, CA, United States of America.,Department of Chemistry, Faculty of Engineering, Istanbul University-Cerrahpasa Avcılar, Istanbul 34320, Turkey
| | - Chun Xu
- Center for Minimally Invasive Therapeutics (C-MIT), University of California, Los Angeles, CA, United States of America.,Department of Bioengineering, University of California, Los Angeles, CA, United States of America.,School of Dentistry, The University of Queensland, Brisbane, Australia
| | - Arshia Mirjafari
- Center for Minimally Invasive Therapeutics (C-MIT), University of California, Los Angeles, CA, United States of America.,Department of Bioengineering, University of California, Los Angeles, CA, United States of America
| | - Fabrizio Billi
- UCLA/OIC Department of Orthopaedic Surgery, David Geffen School of Medicine, UCLA, Los Angeles, CA, United States of America
| | - Wojciech Swieszkowski
- Biomaterials Group, Materials Design Division, Faculty of Materials Science and Engineering, Warsaw University of Technology, Warsaw, Poland
| | - Fatemeh Nasrollahi
- Center for Minimally Invasive Therapeutics (C-MIT), University of California, Los Angeles, CA, United States of America.,Department of Bioengineering, University of California, Los Angeles, CA, United States of America.,Terasaki Institute for Biomedical Innovation, Los Angeles, CA, United States of America
| | - Samad Ahadian
- Center for Minimally Invasive Therapeutics (C-MIT), University of California, Los Angeles, CA, United States of America.,Department of Bioengineering, University of California, Los Angeles, CA, United States of America.,Terasaki Institute for Biomedical Innovation, Los Angeles, CA, United States of America
| | - Vahid Hosseini
- Center for Minimally Invasive Therapeutics (C-MIT), University of California, Los Angeles, CA, United States of America.,Department of Bioengineering, University of California, Los Angeles, CA, United States of America.,Terasaki Institute for Biomedical Innovation, Los Angeles, CA, United States of America
| | - Ali Khademhosseini
- Center for Minimally Invasive Therapeutics (C-MIT), University of California, Los Angeles, CA, United States of America.,Department of Bioengineering, University of California, Los Angeles, CA, United States of America.,Department of Radiological Sciences, David Geffen School of Medicine, University of California, Los Angeles, CA, United States of America.,Terasaki Institute for Biomedical Innovation, Los Angeles, CA, United States of America.,Department of Chemical Engineering, University of California, Los Angeles, CA, United States of America
| | - Nureddin Ashammakhi
- Center for Minimally Invasive Therapeutics (C-MIT), University of California, Los Angeles, CA, United States of America.,Department of Radiological Sciences, David Geffen School of Medicine, University of California, Los Angeles, CA, United States of America.,Department of Biomedical Engineering, College of Engineering, Michigan State University, MI, United States of America
| |
Collapse
|
7
|
Nasrollahi F, Nazir F, Tavafoghi M, Hosseini V, Ali Darabi M, Paramelle D, Khademhosseini A, Ahadian S. Graphene Quantum Dots for Fluorescent Labeling of Gelatin‐Based Shear‐Thinning Hydrogels. Adv NanoBio Res 2021. [DOI: 10.1002/anbr.202170073] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
Affiliation(s)
- Fatemeh Nasrollahi
- Department of Bioengineering University of California-Los Angeles Los Angeles CA 90095 USA
- Center for Minimally Invasive Therapeutics (C-MIT) University of California-Los Angeles Los Angeles CA 90095 USA
- Terasaki Institute for Biomedical Innovation (TIBI) Los Angeles CA 90024 USA
| | - Farzana Nazir
- Department of Bioengineering University of California-Los Angeles Los Angeles CA 90095 USA
- Center for Minimally Invasive Therapeutics (C-MIT) University of California-Los Angeles Los Angeles CA 90095 USA
- Department of Chemistry School of Natural Sciences National University of Science and Technology (NUST) Islamabad 44000 Pakistan
| | - Maryam Tavafoghi
- Department of Bioengineering University of California-Los Angeles Los Angeles CA 90095 USA
- Center for Minimally Invasive Therapeutics (C-MIT) University of California-Los Angeles Los Angeles CA 90095 USA
| | - Vahid Hosseini
- Department of Bioengineering University of California-Los Angeles Los Angeles CA 90095 USA
- Center for Minimally Invasive Therapeutics (C-MIT) University of California-Los Angeles Los Angeles CA 90095 USA
- Terasaki Institute for Biomedical Innovation (TIBI) Los Angeles CA 90024 USA
| | - Mohammad Ali Darabi
- Department of Bioengineering University of California-Los Angeles Los Angeles CA 90095 USA
- Center for Minimally Invasive Therapeutics (C-MIT) University of California-Los Angeles Los Angeles CA 90095 USA
- Terasaki Institute for Biomedical Innovation (TIBI) Los Angeles CA 90024 USA
| | - David Paramelle
- Institute of Materials Research and Engineering A*STAR (Agency for Science, Technology and Research) 2 Fusionopolis Way, Innovis #08-03 Singapore 138634 Singapore
| | - Ali Khademhosseini
- Terasaki Institute for Biomedical Innovation (TIBI) Los Angeles CA 90024 USA
| | - Samad Ahadian
- Terasaki Institute for Biomedical Innovation (TIBI) Los Angeles CA 90024 USA
| |
Collapse
|
8
|
Nasrollahi F, Nazir F, Tavafoghi M, Hosseini V, Ali Darabi M, Paramelle D, Khademhosseini A, Ahadian S. Graphene Quantum Dots for Fluorescent Labeling of Gelatin‐Based Shear‐Thinning Hydrogels. Adv NanoBio Res 2021. [DOI: 10.1002/anbr.202000113] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022] Open
Affiliation(s)
- Fatemeh Nasrollahi
- Department of Bioengineering University of California-Los Angeles Los Angeles CA 90095 USA
- Center for Minimally Invasive Therapeutics (C-MIT) University of California-Los Angeles Los Angeles CA 90095 USA
- Terasaki Institute for Biomedical Innovation (TIBI) Los Angeles CA 90024 USA
| | - Farzana Nazir
- Department of Bioengineering University of California-Los Angeles Los Angeles CA 90095 USA
- Center for Minimally Invasive Therapeutics (C-MIT) University of California-Los Angeles Los Angeles CA 90095 USA
- Department of Chemistry School of Natural Sciences National University of Science and Technology (NUST) Islamabad 44000 Pakistan
| | - Maryam Tavafoghi
- Department of Bioengineering University of California-Los Angeles Los Angeles CA 90095 USA
- Center for Minimally Invasive Therapeutics (C-MIT) University of California-Los Angeles Los Angeles CA 90095 USA
| | - Vahid Hosseini
- Department of Bioengineering University of California-Los Angeles Los Angeles CA 90095 USA
- Center for Minimally Invasive Therapeutics (C-MIT) University of California-Los Angeles Los Angeles CA 90095 USA
- Terasaki Institute for Biomedical Innovation (TIBI) Los Angeles CA 90024 USA
| | - Mohammad Ali Darabi
- Department of Bioengineering University of California-Los Angeles Los Angeles CA 90095 USA
- Center for Minimally Invasive Therapeutics (C-MIT) University of California-Los Angeles Los Angeles CA 90095 USA
- Terasaki Institute for Biomedical Innovation (TIBI) Los Angeles CA 90024 USA
| | - David Paramelle
- Institute of Materials Research and Engineering A*STAR (Agency for Science, Technology and Research) 2 Fusionopolis Way, Innovis #08-03 Singapore 138634 Singapore
| | - Ali Khademhosseini
- Terasaki Institute for Biomedical Innovation (TIBI) Los Angeles CA 90024 USA
| | - Samad Ahadian
- Terasaki Institute for Biomedical Innovation (TIBI) Los Angeles CA 90024 USA
| |
Collapse
|
9
|
Hosseini V, Mallone A, Nasrollahi F, Ostrovidov S, Nasiri R, Mahmoodi M, Haghniaz R, Baidya A, Salek MM, Darabi MA, Orive G, Shamloo A, Dokmeci MR, Ahadian S, Khademhosseini A. Healthy and diseased in vitro models of vascular systems. Lab Chip 2021; 21:641-659. [PMID: 33507199 DOI: 10.1039/d0lc00464b] [Citation(s) in RCA: 16] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/12/2023]
Abstract
Irregular hemodynamics affects the progression of various vascular diseases, such atherosclerosis or aneurysms. Despite the extensive hemodynamics studies on animal models, the inter-species differences between humans and animals hamper the translation of such findings. Recent advances in vascular tissue engineering and the suitability of in vitro models for interim analysis have increased the use of in vitro human vascular tissue models. Although the effect of flow on endothelial cell (EC) pathophysiology and EC-flow interactions have been vastly studied in two-dimensional systems, they cannot be used to understand the effect of other micro- and macro-environmental parameters associated with vessel wall diseases. To generate an ideal in vitro model of the vascular system, essential criteria should be included: 1) the presence of smooth muscle cells or perivascular cells underneath an EC monolayer, 2) an elastic mechanical response of tissue to pulsatile flow pressure, 3) flow conditions that accurately mimic the hemodynamics of diseases, and 4) geometrical features required for pathophysiological flow. In this paper, we review currently available in vitro models that include flow dynamics and discuss studies that have tried to address the criteria mentioned above. Finally, we critically review in vitro fluidic models of atherosclerosis, aneurysm, and thrombosis.
Collapse
Affiliation(s)
- Vahid Hosseini
- Center for Minimally Invasive Therapeutics (C-MIT), University of California-Los Angeles, CA 90095, USA and California NanoSystems Institute and Department of Bioengineering, University of California-Los Angeles, CA 90095, USA and Terasaki Institute for Biomedical Innovation, Los Angeles, CA 90024, USA.
| | - Anna Mallone
- Institute of Regenerative Medicine, University of Zurich, Zurich CH-8952, Switzerland
| | - Fatemeh Nasrollahi
- Center for Minimally Invasive Therapeutics (C-MIT), University of California-Los Angeles, CA 90095, USA and California NanoSystems Institute and Department of Bioengineering, University of California-Los Angeles, CA 90095, USA and Terasaki Institute for Biomedical Innovation, Los Angeles, CA 90024, USA.
| | - Serge Ostrovidov
- Center for Minimally Invasive Therapeutics (C-MIT), University of California-Los Angeles, CA 90095, USA and Department of Radiological Sciences, University of California-Los Angeles, CA 90095, USA
| | - Rohollah Nasiri
- Center for Minimally Invasive Therapeutics (C-MIT), University of California-Los Angeles, CA 90095, USA and California NanoSystems Institute and Department of Bioengineering, University of California-Los Angeles, CA 90095, USA and Department of Mechanical Engineering, Sharif University of Technology, Tehran 1136511155, Iran
| | - Mahboobeh Mahmoodi
- Center for Minimally Invasive Therapeutics (C-MIT), University of California-Los Angeles, CA 90095, USA and California NanoSystems Institute and Department of Bioengineering, University of California-Los Angeles, CA 90095, USA and Department of Biomedical Engineering, Yazd Branch, Islamic Azad University, Yazd 8915813135, Iran
| | - Reihaneh Haghniaz
- Center for Minimally Invasive Therapeutics (C-MIT), University of California-Los Angeles, CA 90095, USA and California NanoSystems Institute and Department of Bioengineering, University of California-Los Angeles, CA 90095, USA and Terasaki Institute for Biomedical Innovation, Los Angeles, CA 90024, USA.
| | - Avijit Baidya
- Center for Minimally Invasive Therapeutics (C-MIT), University of California-Los Angeles, CA 90095, USA and California NanoSystems Institute and Department of Bioengineering, University of California-Los Angeles, CA 90095, USA
| | - M Mehdi Salek
- School of Engineering, Massachusetts Institute of Technology (MIT), Cambridge, MA 02139, USA
| | - Mohammad Ali Darabi
- Center for Minimally Invasive Therapeutics (C-MIT), University of California-Los Angeles, CA 90095, USA and California NanoSystems Institute and Department of Bioengineering, University of California-Los Angeles, CA 90095, USA and Terasaki Institute for Biomedical Innovation, Los Angeles, CA 90024, USA.
| | - Gorka Orive
- NanoBioCel Group, Laboratory of Pharmaceutics, School of Pharmacy, University of the Basque Country UPV/EHU, Paseo de la Universidad 7, Vitoria-Gasteiz 01006, Spain and Biomedical Research Networking Centre in Bioengineering, Biomaterials, and Nanomedicine (CIBER-BBN), Vitoria-Gasteiz 01007, Spain
| | - Amir Shamloo
- Department of Mechanical Engineering, Sharif University of Technology, Tehran 1136511155, Iran
| | - Mehmet R Dokmeci
- Center for Minimally Invasive Therapeutics (C-MIT), University of California-Los Angeles, CA 90095, USA and California NanoSystems Institute and Department of Bioengineering, University of California-Los Angeles, CA 90095, USA and Terasaki Institute for Biomedical Innovation, Los Angeles, CA 90024, USA.
| | - Samad Ahadian
- Center for Minimally Invasive Therapeutics (C-MIT), University of California-Los Angeles, CA 90095, USA and California NanoSystems Institute and Department of Bioengineering, University of California-Los Angeles, CA 90095, USA and Terasaki Institute for Biomedical Innovation, Los Angeles, CA 90024, USA.
| | - Ali Khademhosseini
- Center for Minimally Invasive Therapeutics (C-MIT), University of California-Los Angeles, CA 90095, USA and California NanoSystems Institute and Department of Bioengineering, University of California-Los Angeles, CA 90095, USA and Terasaki Institute for Biomedical Innovation, Los Angeles, CA 90024, USA.
| |
Collapse
|
10
|
Nasrollahi F, Sana B, Paramelle D, Ahadian S, Khademhosseini A, Lim S. Incorporation of Graphene Quantum Dots, Iron, and Doxorubicin in/on Ferritin Nanocages for Bimodal Imaging and Drug Delivery. Adv Therap 2020. [DOI: 10.1002/adtp.201900183] [Citation(s) in RCA: 20] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/17/2023]
Affiliation(s)
- Fatemeh Nasrollahi
- School of Chemical and Biomedical EngineeringNanyang Technological University 70 Nanyang Drive, Block N1.3 Singapore 637457
- Center for Minimally Invasive Therapeutics (C‐MIT)University of California—Los Angeles Los Angeles CA 90095 USA
- Department of BioengineeringUniversity of California—Los Angeles Los Angeles CA 90095 USA
- School of Chemical Engineering, College of EngineeringUniversity of Tehran P.O. Box: 11155/4563 Tehran Iran
| | - Barindra Sana
- School of Chemical and Biomedical EngineeringNanyang Technological University 70 Nanyang Drive, Block N1.3 Singapore 637457
- p53 LaboratoryAgency for Science Technology and Research (A*STAR) 8A Biomedical Grove Singapore 138648
| | - David Paramelle
- Institute of Materials Research and EngineeringA*STAR (Agency for Science, Technology and Research) 2 Fusionopolis Way, Innovis #08‐03 Singapore 138634
| | - Samad Ahadian
- Center for Minimally Invasive Therapeutics (C‐MIT)University of California—Los Angeles Los Angeles CA 90095 USA
- Department of BioengineeringUniversity of California—Los Angeles Los Angeles CA 90095 USA
| | - Ali Khademhosseini
- Center for Minimally Invasive Therapeutics (C‐MIT)University of California—Los Angeles Los Angeles CA 90095 USA
- Department of BioengineeringUniversity of California—Los Angeles Los Angeles CA 90095 USA
- Department of Radiological Sciences, David Geffen School of MedicineDepartment of Chemical and Biomolecular EngineeringUniversity of California—Los Angeles Los Angeles CA 90095 USA
| | - Sierin Lim
- School of Chemical and Biomedical EngineeringNanyang Technological University 70 Nanyang Drive, Block N1.3 Singapore 637457
- NTU‐Northwestern Institute for Nanomedicine (NNIN)Nanyang Technological University 50 Nanyang Drive, Block N3.1, #01‐03 Singapore 637553
| |
Collapse
|
11
|
Nasrollahi F, Koh YR, Chen P, Varshosaz J, Khodadadi AA, Lim S. Targeting graphene quantum dots to epidermal growth factor receptor for delivery of cisplatin and cellular imaging. Materials Science and Engineering: C 2019; 94:247-257. [DOI: 10.1016/j.msec.2018.09.020] [Citation(s) in RCA: 43] [Impact Index Per Article: 8.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/27/2018] [Revised: 08/03/2018] [Accepted: 09/07/2018] [Indexed: 12/18/2022]
|
12
|
Nasrollahi F, McLachlan D, Makin C, Arangan J, Stevenson M, Huang J, Reed M, Vinson D. 374 Prevalence and Prognosis of Delayed Diagnosis of Acute Pulmonary Embolism. Ann Emerg Med 2018. [DOI: 10.1016/j.annemergmed.2018.08.379] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
13
|
Nasrollahi F, Varshosaz J, Khodadadi AA, Lim S, Jahanian-Najafabadi A. Targeted Delivery of Docetaxel by Use of Transferrin/Poly(allylamine hydrochloride)-functionalized Graphene Oxide Nanocarrier. ACS Appl Mater Interfaces 2016; 8:13282-93. [PMID: 27158834 DOI: 10.1021/acsami.6b02790] [Citation(s) in RCA: 58] [Impact Index Per Article: 7.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/24/2023]
Abstract
The exceptional chemical and physical properties of graphene oxide (GO) make it an attractive nanomaterial for biomedical applications, particularly in drug delivery. In this work we synthesized a novel, GO-based nanocarrier for the delivery of docetaxel (DTX), a potent hydrophobic chemotherapy drug. The GO was functionalized with transferrin (Tf)-poly(allylamine hydrochloride) (PAH), which provided targeted and specific accumulation to extracellular Tf receptors and stabilized GO in physiological solutions. Tf was conjugated to PAH via amide covalent linkages, and Tf-PAH coated the surface of DTX-loaded GO through electrostatic interactions. The morphology and structure of the resulting nanostructure, along with its surface modifications, were verified by use of Fourier transform infrared (FT-IR) and UV-vis spectroscopy, atomic force microscopy (AFM), and scanning electron microscopy (SEM). DTX was loaded at a relatively high loading capacity of 37% and released in a pH-dependent and sustained manner under physiological conditions. The targeting efficiency and cytotoxicity of this drug delivery system were evaluated on MCF-7 breast cancer cells. Improved efficacy of targeted DTX-loaded nanocarrier was observed compared to nontargeted carrier and free DTX, especially at high drug concentrations. The Tf-PAH-functionalized GO nanocarrier is a promising candidate for targeted delivery and controlled release of DTX.
Collapse
Affiliation(s)
- Fatemeh Nasrollahi
- Catalysis and Nanostructured Materials Laboratory, School of Chemical Engineering, College of Engineering, University of Tehran , Post Office Box 11155/4563, Tehran, Iran
- School of Chemical and Biomedical Engineering, Nanyang Technological University , 70 Nanyang Drive, Block N1.3, Singapore 637457
| | | | - Abbas Ali Khodadadi
- Catalysis and Nanostructured Materials Laboratory, School of Chemical Engineering, College of Engineering, University of Tehran , Post Office Box 11155/4563, Tehran, Iran
| | - Sierin Lim
- School of Chemical and Biomedical Engineering, Nanyang Technological University , 70 Nanyang Drive, Block N1.3, Singapore 637457
| | | |
Collapse
|
14
|
Nasrollahi F, Bakeri G, Ismail AF, Rahimnejad M, Imanian M. Development of a model for dimethyl ether non-adiabatic reactors to improve methanol conversion. KOREAN J CHEM ENG 2013. [DOI: 10.1007/s11814-013-0138-0] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|